Tocris Signs Exclusive Deal to Supply Gefitinib for Cancer Research 05 September 2008 Tocris Bioscience announced today the signing of an exclusive deal with AstraZeneca to supply Gefitinib to preclinical researchers working on the mechanisms underlying cancer development.
Gene Expression Study to Develop Prognostic Test for Early Non-Small Cell Lung Cancer 04 September 2008 Almac Diagnostics has announced details of a global multi-centre collaborative lung cancer study with leading research organisations in the USA, Canada, Asia and Europe.
Genetix Group plc Awarded Scottish NHS Cytogenetics Contract 03 September 2008 Over 70 CytoVision® workstations to provide an automated solution for Scotland’s entire network of cytogenetic laboratories.
NIH Funds Nine Centers to Speed Application of Powerful New Research Approach 03 September 2008 The funding of a network of nine centers across the country that will use high tech screening methods to identify small molecules for use as probes to investigate the diverse functions of cells was announced today by the National Institutes of Health (NIH).
New UK laboratory to focus on important medical targets 02 September 2008 The official opening of the Membrane Protein Laboratory (MPL) took place at Diamond Light Source in Oxfordshire, UK. The MPL at Diamond is a research and training facility for scientists interested in solving the 3-dimensional structures of membrane proteins by X-ray crystallography.
Dyax and AVEO Pharmaceuticals Announce Antibody Library License Agreement 26 August 2008 Dyax has granted AVEO a non-exclusive license to its proprietary antibody phage display libraries for the discovery and development of therapeutic antibodies.
Duke Chemists Synthesize Promising Anti-Cancer Product 26 August 2008 The researchers have patented an efficient technique that allows algae extract to be further evaluated for tailored cell-killing traits.
Isogen Biosolutions B.V. is now Ocimum Biosolutions B. V. 13 August 2008 Isogen has rebranded itself as Ocimum Biosolutions B. V. to tap the emerging opportunities and need for globalized solutions in Genomics.